Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
about
14-3-3zeta Cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transitionTransforming growth factor beta1 signaling via interaction with cell surface Hyal-2 and recruitment of WWOX/WOX1Silencing of the transforming growth factor-beta (TGFbeta) receptor II by Kruppel-like factor 14 underscores the importance of a negative feedback mechanism in TGFbeta signalingE-cadherin's dark side: possible role in tumor progressionEpithelial-to-mesenchymal transition in breast cancer: a role for insulin-like growth factor I and insulin-like growth factor-binding protein 3?Gamma-ray irradiation impairs dendritic cell migration to CCL19 by down-regulation of CCR7 and induction of cell apoptosisSMAD proteins control DROSHA-mediated microRNA maturationTGF-β signaling in T cells: roles in lymphoid and epithelial neoplasiaTransforming growth factor beta controls the directional migration of hepatocyte cohorts by modulating their adhesion to fibronectin.DEAR1 is a chromosome 1p35 tumor suppressor and master regulator of TGF-β-driven epithelial-mesenchymal transitionGlobal gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroidsCytokine plasma levels: reliable predictors for radiation pneumonitis?Gene expression profile and genomic alterations in colonic tumours induced by 1,2-dimethylhydrazine (DMH) in rats.Anterior diffuse retinoblastoma: mutational analysis and immunofluorescence staining.Two faces of TGF-beta1 in breast cancer.Network based transcription factor analysis of regenerating axolotl limbsNDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression.SMAD4 is a potential prognostic marker in human breast carcinomas.Genetic suppression of inflammation blocks the tumor-promoting effects of TGF-β in gastric tissue.Transforming growth factor-β1 and -β2 in gastric precancer and cancer and roles in tumor-cell interactions with peripheral blood mononuclear cells in vitroWhat can we learn from rodents about prolactin in humans?MiR-21 plays an important role in radiation induced carcinogenesis in BALB/c mice by directly targeting the tumor suppressor gene Big-h3.Blockade of transforming growth factor-beta (TGFβ) signaling inhibits osteoblastic tumorigenesis by a novel human prostate cancer cell lineRemodeling of extracellular matrix by normal and tumor-associated fibroblasts promotes cervical cancer progression.Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.Pleiotropic functions of EAPII/TTRAP/TDP2: cancer development, chemoresistance and beyondSecreted heat shock protein-90 (Hsp90) in wound healing and cancer.Role of the CacyBP/SIP protein in gastric cancerNickel inhibits mitochondrial fatty acid oxidation.Mesodermal ALK5 controls lung myofibroblast versus lipofibroblast cell fate.Tumor suppressor genetics.CacyBP/SIP promotes the proliferation of colon cancer cellsPrognostic value of transforming growth factor-beta in patients with colorectal cancer who undergo surgery: a meta-analysisMathematical model of TGF-βsignalling: feedback coupling is consistent with signal switching.Embryonic morphogen nodal promotes breast cancer growth and progression.Production of gastrointestinal tumors in mice by modulating latent TGF-β1 activationLessons on the pathogenesis of aneurysm from heritable conditionsInactivating mutations in GNA13 and RHOA in Burkitt's lymphoma and diffuse large B-cell lymphoma: a tumor suppressor function for the Gα13/RhoA axis in B cells.Smad2 functions as a co-activator of canonical Wnt/beta-catenin signaling pathway independent of Smad4 through histone acetyltransferase activity of p300.Targeting TGF-β1 inhibits invasion of anaplastic thyroid carcinoma cell through SMAD2-dependent S100A4-MMP-2/9 signalling.
P2860
Q24313042-EB67D0E5-84DE-4FCB-BA5E-4FF76D75E768Q24315728-F068778A-9138-42A8-A498-AA6E30753B33Q24647149-40314DCE-5074-46F0-B7F2-BE27C83BC997Q26865483-DCF0BF7E-6229-4A87-8F91-09BFD9772561Q28087055-E7980059-C28F-4378-B8CB-C7C5EBDCADDEQ28386637-4B277E89-9F4C-431C-B790-A98F9A9DA558Q28941771-F36C7E09-E103-41A5-B837-95D754EE19D1Q29036999-64A65338-2A74-47A9-8592-2CFCFB720A71Q30481397-2929FCE7-E225-40B1-9C9F-388E1E2155EAQ30584686-6C5F6D24-9320-4C43-BFF5-97391D0206F0Q33321330-6ACE1703-3F3C-4A80-9CA7-FF5E1DC1AFBAQ33358117-D4E61550-D5EA-4112-88B6-1E8FCD3B64D1Q33575552-E2DF30D0-959D-461C-B5A0-369F5CC66A20Q33606739-8CC58B3E-8CBD-4A7D-B518-F53B0FF22B07Q33661529-58FCFF34-65E5-4728-8311-54549D4ECC4AQ33850285-45A5FA2C-A26F-46B9-9012-063BDF4FE115Q33933777-A9A4B4D5-7DF5-4119-A548-6D3AFD9A1D1DQ34079958-2FB82104-79F3-4441-B5E7-F229CF2AF6CAQ34154062-13016460-E70D-49EB-B211-CDC387F686E7Q34559243-308D6967-8997-41C8-928E-288B3BF4052CQ34721567-59F95940-850E-46E9-9547-68CC62D00D6BQ34791957-0D1E7F9C-E620-48F6-94BC-CA962534F3C5Q35024363-24DA803A-8FB6-49C8-B081-B54F3C41F8DDQ35538088-64E28578-4C5B-4353-B6D9-C9F7D4F6E123Q35570431-5B06CE49-3668-4FC3-9C6D-353FC61C8DBFQ35600743-4FB15571-4530-471C-BD53-E3B9BF2324C7Q35696767-23048FBE-A38B-4CCB-8269-08523645804BQ35742059-C4A904A0-7B5A-402E-82BC-3FCCFBEA1DE1Q35836537-7961FC77-BAF7-457F-A61B-02F8B3EF5F0EQ35960236-711D3F32-78CA-4E60-A269-41EBB18EE748Q36252762-D184A288-EF01-4C20-82D9-39361EB292C3Q36279916-95A06AEF-1C76-45E6-9FA4-BB8DE5BDDABCQ36334645-FF3F2694-CC73-4918-8A0F-3EEF372EBDF9Q36346393-6D07BDA2-9FE9-4F6D-A088-EB04206BE8D9Q36380822-8551FF2E-C46F-49B4-8003-0635016CC671Q36510874-699B3B6E-3572-4396-AD5D-00B2BC1DEC70Q36756427-AA4C7B47-081D-43C3-81B2-C092C1526260Q36948524-3D51B9F4-D361-4ACD-B455-37B85E56849DQ36962785-C32EF8B6-7631-4465-83E5-F7CB2BB4FFF5Q36964131-60AE3466-70D7-4723-9AD6-B03BBC42D516
P2860
Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
@ast
Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
@en
type
label
Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
@ast
Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
@en
prefLabel
Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
@ast
Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
@en
P1476
Duel nature of TGF-beta signaling: tumor suppressor vs. tumor promoter.
@en
P2093
Ben Ho Park
P356
10.1097/01.CCO.0000143682.45316.AE
P50
P577
2005-01-01T00:00:00Z